NeoAccess™, the new clinical decision-support platform for oncologists was built on user experience (UX) and design thinking principles to ensure an intuitive interface that eases clinical workflow.
NeoGenomics received a platinum award from DotCOMM, an international competition honoring excellence in web creativity and digital communication. Other 2023 winners include Amazon Science, United Healthcare, CVS Health, and Cigna Healthcare.
We were recognized for the design of NeoAccess. This new online ordering platform streamlines precision oncology decision-making and test ordering to deliver a simple, time-saving experience for busy oncologists and staff members.
NeoAccess was developed according to design thinking principles that apply user-driven insight to platform interface design. Karan Cushman, Head of Brand Experience for NeoAccess, notes that “design thinking is a user-centered philosophy that continually focuses on the wants, needs, and pain points of its audience. Rooted in this understanding, our team has developed deep expertise in supporting oncologists and staff over the past decade as advancements in precision medicine accelerate and present new challenges for clinicians.”
The result is a technology platform that speeds the clinical decision-making process, simplifies finding the right tests based on current guidelines and FDA drug indications and enables oncologists to easily order them from NeoGenomics’ comprehensive testing menu. Oncologists who use NeoAccess can also check patient benefits and estimate out-of-pocket costs in real-time.
With this platinum award, the NeoAccess team is proud to be recognized for its innovative new platform. We invite you to learn more about NeoAccess and request a demo to see how it is helping advance precision oncology testing.